Skip to content
Search

Latest Stories

GPhC forms Anti-Racism Champions to promote inclusivity in pharmacy

GPhC forms Anti-Racism Champions to promote inclusivity in pharmacy

Pharmacy professionals continue to experience discrimination and racism in practice, even at the most senior levels

The General Pharmaceutical Council (GPhC) has taken a significant step towards advancing its anti-racism agenda by forming a new working group of "Anti-Racism Champions."

Comprising existing GPhC Council and Executive members, the group is committed to providing visible and vocal leadership, internally and externally, to combat racism and promote inclusivity across the pharmacy sector.


The formation of this working group follows the GPhC's recent Governing Council discussion in July, which focused on the next steps in its ‘Racism in Pharmacy’ work.

This initiative is an important part of the GPhC's wider Equality, Diversity, and Inclusion (EDI) strategy, aimed at proactively addressing discrimination and reducing health inequalities through the Council's regulatory influence.

The Anti-Racism Champions group includes people with lived experience of racism and allies who will help shape future action.

The group members are:

  • Gisela Abbam, Chair of Council
  • Ade Williams, pharmacist member of Council
  • Ann Jacklin, pharmacist member of Council
  • Gareth Powell, lay member of Council
  • Dionne Spence, Chief Enforcement Officer and Deputy Registrar
  • Louise Edwards, Chief Strategy Officer and Deputy Registrar
  • Laura McClintock, Chief of Staff

The GPhC highlighted that pharmacy professionals continue to experience discrimination and racism in practice and throughout their careers, even at the most senior levels, noting that “We should all be determined to change this.”

“We want to promote and foster a workplace environment within the pharmacy profession where every individual feels valued, included, and empowered to contribute meaningfully, at all levels.

“The new group will help us drive forward our commitments in this area, holding ourselves to the same high standards we expect of others,” the regulator said.

The GPhC's next anti-racism efforts build on their earlier equality roundtables and associated reports.

The Council will be discussing our wider EDI work in public session in September, with an update on all of the activity completed in 2023/24 (Year 2) of our strategy.

The Council will further discuss its broader EDI work during a public session in September, where an update on all of the activity completed in 2023/24 (Year 2) of the strategy will be presented.

 

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less